Adiela Correa Marinez1, Elisabeth González2, Kajsa Holm2, David Bock2, Mattias Prytz2,3, Eva Haglind2, Eva Angenete2. 1. Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SSORG-Scandinavian Surgical Outcomes Research Group, Sahlgrenska University Hospital/Östra, SE-416 85, Gothenburg, Sweden. adiela-adriana.correa-marinez@vgregion.se. 2. Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SSORG-Scandinavian Surgical Outcomes Research Group, Sahlgrenska University Hospital/Östra, SE-416 85, Gothenburg, Sweden. 3. Department of Surgery, NU-hospital Group, Trollhättan, Sweden.
Abstract
PURPOSE: The primary aim of this study was to characterize the frequency, severity, and distress of symptoms from the colostomy and colostomy acceptance in rectal cancer patients. The secondary aims were to study the symptomatic parastomal herniation, its relationship to stoma-related symptoms, and potential risk factors for the development of symptomatic parastomal herniation. METHODS: Data was collected from the Swedish Colorectal Cancer Registry and from surgical charts. Patients operated for rectal cancer with an abdominoperineal excision in Sweden between 2007 and 2009 and alive 3 years postoperatively were contacted (n = 852). Patients who consented to participate, had a colostomy constructed during the abdominoperineal excision, and who answered a questionnaire 3 years postoperative were included (n = 495). Answers were analyzed with emphasis on stoma-related symptoms and their intensity as well as the level of distress associated with the symptoms. RESULTS: Almost 90% of patients did not feel limited in their daily life by their colostomy. Patients with symptomatic parastomal hernia had a 53% higher risk of flatulence. Fifty-six patients developed symptomatic parastomal hernia (11%). The only risk factor associated with the development of symptomatic parastomal hernia was high body mass index (BMI). CONCLUSIONS: This study shows that most patients do not feel limited by their stoma 3 years after surgery for rectal cancer. Symptomatic parastomal hernia was associated with high BMI but not with the surgical technique.
PURPOSE: The primary aim of this study was to characterize the frequency, severity, and distress of symptoms from the colostomy and colostomy acceptance in rectal cancerpatients. The secondary aims were to study the symptomatic parastomal herniation, its relationship to stoma-related symptoms, and potential risk factors for the development of symptomatic parastomal herniation. METHODS: Data was collected from the Swedish Colorectal Cancer Registry and from surgical charts. Patients operated for rectal cancer with an abdominoperineal excision in Sweden between 2007 and 2009 and alive 3 years postoperatively were contacted (n = 852). Patients who consented to participate, had a colostomy constructed during the abdominoperineal excision, and who answered a questionnaire 3 years postoperative were included (n = 495). Answers were analyzed with emphasis on stoma-related symptoms and their intensity as well as the level of distress associated with the symptoms. RESULTS: Almost 90% of patients did not feel limited in their daily life by their colostomy. Patients with symptomatic parastomal hernia had a 53% higher risk of flatulence. Fifty-six patients developed symptomatic parastomal hernia (11%). The only risk factor associated with the development of symptomatic parastomal hernia was high body mass index (BMI). CONCLUSIONS: This study shows that most patients do not feel limited by their stoma 3 years after surgery for rectal cancer. Symptomatic parastomal hernia was associated with high BMI but not with the surgical technique.
Entities:
Keywords:
Parastomal hernia; Quality of life; Rectal neoplasm; Stoma
Authors: M López-Cano; R Lozoya-Trujillo; S Quiroga; J L Sánchez; F Vallribera; M Martí; L M Jiménez; M Armengol-Carrasco; E Espín Journal: Hernia Date: 2012-07-11 Impact factor: 4.739
Authors: Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg Journal: N Engl J Med Date: 2002-09-12 Impact factor: 91.245
Authors: Marianne Krogsgaard; Helle Ø Kristensen; Edgar J B Furnée; Sanne J Verkuijl; Nuno José Rama; Hugo Domingos; João Maciel; Alejandro Solis-Peña; Eloy Espín-Basany; Marta Hidalgo-Pujol; Sebastiano Biondo; Annika Sjövall; Katrine J Emmertsen; Anne Thyø; Peter Christensen Journal: Support Care Cancer Date: 2022-08-05 Impact factor: 3.359
Authors: Dan Asplund; Thue Bisgaard; David Bock; Jakob Burcharth; Elisabeth González; Eva Haglind; Yanislav Kolev; Peter Matthiessen; Carina Rosander; Jacob Rosenberg; Kenneth Smedh; Marina Åkerblom Sörensson; Eva Angenete Journal: Int J Colorectal Dis Date: 2017-09-14 Impact factor: 2.571
Authors: M Sörensson; D Asplund; P Matthiessen; J Rosenberg; T Hallgren; C Rosander; E González; D Bock; E Angenete Journal: Colorectal Dis Date: 2019-12-06 Impact factor: 3.788